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ABSTRACT 
Multiple sclerosis (MS) is the most common demyelinating disease of the 
central nervous system (CNS) and is becoming an increasing concern for 
individuals between the ages of 15 to 50. Multiple sclerosis is a chronic, often 
progressive disease that may result in difficulties with vision, verbal 
communication, sensation, bowel and bladder function, balance, and ambulation. 
The purpose of this study was to determine if significant changes occurred 
in static steadiness, symmetry, and dynamic stability in subjects with MS 
following a retraining program using the NeuroCom Balance Maste~ (NBM®). 
Ten subjects (6 females, 4 males) were placed in a control or treatment group. 
The NBM® was used to assess each subject's balance at week one and four, 
and was also used in the retraining program for the treatment group three times 
per week for four weeks. Results showed a significant difference between 
groups in two components of the dynamic stability tests: endpoint excursion 
forward (p = .042) and maximum excursion endpoint forward (p = .029). No 
significant difference was found in static steadiness or symmetry between 
groups. 
The variability among subjects in the MS population pool, the small 
sample size, and the four-week time frame may have been limiting factors in this 
ix 
study, Further research is needed to determine the effectiveness of a balance 
retraining program using the NBM®, 
x 
CHAPTER I 
INTRODUCTION AND REVIEW OF THE LITERATURE 
Multiple sclerosis (MS) is the most common demyelinating disease of the 
central nervous system (CNS) and is becoming an increasing concern for 
individuals between the ages of 15 to 50. Multiple sclerosis is a chronic, often 
progressive disease that may result in difficulties with vision, verbal 
communication, sensation, bowel and bladder function, balance and ambulation. 
Previous studies have utilized a force platform biofeedback system to assess 
and retrain balance in multiple patient populations, including hemiplegia. No 
research to date has been conducted utilizing a biofeedback system to assess 
and retrain balance of persons with MS. 
This paper will provide the reader with a description of the etiology and 
associated signs and symptoms of MS as well as the different categories and 
course of MS. Diagnosis and treatment of MS will also be covered, with 
emphasis placed on the treatment of balance impairments so often associated 
with MS. The three systems necessary for adequate postural stability-visual, 
vestibular, and somatosensory-will also be discussed. 
Multiple Sclerosis 
Multiple sclerosis is a chronic, demyelinating disease affecting the white 
matter of the central nervous system (CNS).1.s It was described as early as six 
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centuries ago and is considered to be the most common disease affecting the 
myelin of the CNS. 1 In fact, besides certain mental disorders and neurological 
injuries secondary to trauma, MS is the most common disease affecting the 
nervous system of young adults. 1,4 Multiple sclerosis is most commonly 
characterized by relapses, or exacerbations, of active disease lasting from 48 
hours to several weeks, followed by lengthy periods of improvement, or 
remission, where symptoms may diminish or even disappear for periods of 
months to years. 1,4,6 
Multiple sclerosis is considered to be a primary demyelinating disease 
because it attacks the myelin sheaths while sparing the axons.3 Following the 
destruction of the sheath, patchy areas of inflammation are found along the 
CNS. Scar tissue and plaques, or 'sclerosed' areas, are then formed where the 
myelin sheath previously served to protect and insulate the nerve fibers. 
Because of the destruction of the myelin sheath, the conduction of the nervous 
impulse is short-circuited, interrupted, blocked, or slowed. 1,2 With the 
progression of MS, new plaques form, old plaques expand, and nearby plaques 
join to form larger sclerosed areas. 1 Remarkably, it is not rare to find plaques 
two to three centimeters wide and several centimeters long.4 In active plaques, 
the sclerosed areas continue to harden and contract, permanently damaging 
some nerve fibers running through them. In older plaques, astroglia invade the 
central portion of the scars which were formerly occupied by oligodendroglia, 
white blood cells, some remains of myelin, and other such remnants from the 
3 
inflammatory process.1,3 This is of significance because, without oligodendroglia, 
remyelination will not occur. 
An estimated 250 000-350 000 Americans5,7 have been diagnosed with 
MS, with approximately 200 new cases reported every week.2 Most patients are 
between the ages of 15 and 50, with a mean age of 30, when the disease first 
strikes.1,5,7 Women are diagnosed two times more often than men and 
Caucasians more frequently than Asians or African Americans. 1,2,5,7 The 
prevalence of MS in the United States varies from 15 to more than 100 cases 
per 100 000 persons of all ages.1 Interestingly, MS is more prevalent in colder 
climates2 or those places more distant from the equator, such as the Northern 
U.S., Canada, and Great Britain.1,7 In contrast, MS is quite uncommon in those 
countries near the equator, such as China, Japan, and the Indies.5 The 
incidence of the disease is related to place of residence, especially for the first 
15 years of life.2,5 For instance, migration from a low- to high-risk area during the 
childhood or adolescent years is associated with an increase in rate of MS, while 
migration from a high- to low-risk area during the formative years is related to a 
decrease in the rate of the disease.1 However, adults who immigrate from 
equatorial countries to more northern ones have a lower incidence of MS than 
the natives; while adults who immigrate to more equatorial places have a higher 
incidence of the disease than natives. 
Since MS can affect any part of the CNS, initial symptoms can be quite 
variable.3 The signs and symptoms of MS vary significantly from one 
exacerbation to the next, as well as among individuals.2 Symptoms of this 
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disease most commonly appear, remit, and reappear; often involving other 
areas, as well as with varying degrees of severity.1.5 Certain areas of the CNS 
are more vulnerable to myelin destruction and subsequent scar formation. Signs 
and symptoms of MS are the result of the plaques and sclerosed areas along the 
axon which, in effect, block or distort the conduction of the nerve impulse to and 
from the various centers in the brain.1 Early symptoms of MS most often involve 
sensory rather than motor deficits. For instance, it is not uncommon for an 
individual to initially experience paresthesias in one or more limbs; bowel, 
bladder, and sexual dysfunction; diplopia; blurred vision or other such problems 
associated with optic neuritis; vision loss; loss of proprioception; and vertigo.1-8 
Of the above, sensory involvement of limbs, gait and balance disturbances, 
visual loss, and diplopia are most frequently reported as initial symptoms. 
Balance can be adversely affected by any of the early signs and symptoms 
associated with MS.8 
Late symptoms may include dyscoordination; muscle cramps, weakness, 
and fatigue; spasms; slurred speech; paresis; paralysis; pain; depression or 
other mood changes; spasticity; loss of balance; ataxia; intolerance to heat; and 
intention tremor.1-8 Of these, balance abnormalities were found approximately 
80% of the time throughout the course of the disease.8 Impaired sensation, 
fatigue, paraparesis, visual loss, weakness and dyscoordination of limbs, and 
diplopia were most often reported as symptoms found throughout the course of 
MS. These symptoms are also very much related to balance. Some patients 
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experience memory loss and impairment, decreased mentation, depression, and 
mood sWings.2,4 
Throughout the course of the disease, it is not unusual to experience 
multiple symptoms simultaneously; however, with optic neuritis, people 
commonly present with this singular abnormality.5 Symptoms of MS are most 
often rapid in onset, with variable intensity. Usually early signs and symptoms 
completely remit after six to eight weeks. The persons' ability to perform 
functions of daily life fluctuate from day to day and from attack to attack, and are 
further influenced by fatigue, temperature, type of MS, and other unknown 
factors. 3 An estimated two-thirds of persons with MS are ambulatory throughout 
the course of the disease, but many require assistive devices to do so? It is not 
possible to predict if or when an attack of symptoms will occur; however, 
exacerbations may be the result of certain external factors, such as infections, 
stress, pregnancy, trauma, emotional distress, exposure to cold, surgical 
procedures, and fatigue and over-exertion. 1,3,6 Nonetheless, for the majority of 
relapses, no precipitating factor can be found. 3 
Multiple sclerosis ranges from very mild to intermittent to very severe and 
rapidly progressive forms.2 Since the course of the disease is very unpredictable 
with an astonishing amount of variability between patients, this disease is 
classified into several categories based on the severity and degree of neurologic 
impairment. 7 
Approximately 20% to 35% of patients with MS experience mild symptoms 
that either remit suddenly or over time or are never even detected. This category 
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in which people experience no or very few attacks with no recurrence afterward 
is known as benign MS.1,2,S,8 With benign MS, onset of symptoms usually include 
optic neuritis and paresthesias of limbs and trunk. Remission is complete, and 
severe or permanent disability does not develop.3 
The majority of patients with MS-some 50% to 65%-have unpredictable 
attacks followed by bouts of remission lasting months or even years. 1,2,S This 
category of MS, which is characterized by numerous exacerbations and 
remissions of signs and symptoms, is known as the relapsing-remitting type. It is 
not uncommon for some of these patients to have only limited disability even 20 
or more years after the diagnosis.s Quite often, after the active period of relapse 
and remission-lasting approximately five years-the pattern of MS changes, 
resulting in no more acute attacks and more spontaneous recoveries.3 
A third category of MS is known as relapsing or chronic/progressive, 
whereby approximately 25% of patients develop significant neurologic 
disability.2,s Some recovery following attacks is observed,8 but approximately 15 
years after the diagnosis, most will require the use of an assistive device for 
gait.s 
The fourth and final type of MS is known as the primary progressive 
type. 1,s Approximately 10% of patients fall into this category and experience a 
progressive course from the onset of the disease, with the absence of 
exacerbations and remissions.3,s Interestingly, this group is comprised mainly of 
older males and usually includes some spinal cord involvement.s 
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In general, patients with MS have a better prognosis if the disease course 
begins earlier in age, if symptoms are primarily sensory versus motor, and if the 
person is of the female gender. 5 Ultimately, approximately 50% of persons with 
MS of the relapsing-remitting, chronic/progressive, and primary progressive 
types will experience a progressive course.7 Rao4 states that the course of the 
disease is typically one that gradually worsens over an almost normal life span. 
The life expectancy of people with MS is only slightly less than in the general 
population7-about 75% of normal. 1 Even though the life span is comparable to 
that of the general population, the quality of life may be quite different than that 
normally found. For instance, many individuals with MS are unable to walk 
effectively or to perform other functions of daily life secondary to the common 
symptoms of weakness, spasticity, dyscoordination, altered balance, and 
disturbances of the visual and somatosensory systems.8 Nonetheless, there are 
many adaptive devices and techniques in addition to environmental modifications 
that make activities of daily living easier and safer for the person with MS. 
What exactly causes MS is unknown,1-4.6-8 although studies have 
suggested that a combination of inherited and environmental factors may be to 
blame.3.6.7 There does appear to be a genetic predisposition in that the rate of 
MS increases slightly when there is a close relative with the diagnosis.1.7 More 
specifically, research suggests that instead of one or two cases of MS per 1000 
in the US, in families where MS is found, the risk increases to three per 100.7 
This is a higher risk, but not a major factor when determining the cause of MS.3 
There is no evidence that MS is directly inherited in the general population2; 
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rather, evidence suggests that persons who develop MS inherit a predisposition 
to the disease, perhaps with a weakness to an offending agent in the 
environment.1 Studies with identical twins-with identical susceptibility 
genes-show that the second twin develops MS only half of the time. Therefore, 
even with evidence suggesting a genetic predisposition, other research shows 
environmental factors are just as important.4 
Studies have suggested that a person's genes are related to the 
susceptibility to and character of MS.1 Research has found that there is an 
increase in the chromosome crossover rate in persons with MS. This is an 
inherited disorder and has that potential to create a disease process. 
Moreover, evidence has suggested that exposure, especially in the 
childhood years, to an offending agent, such as a virus, may cause the MS 
disease process.3,7 Studies have suggested that MS probably begins during 
childhood and adolescence with signs and symptoms not appearing for a period 
of years.1 If such evidence were true, then re-exposure to certain viruses could 
trigger a relapse. Viral theories are supported by the latitude effect and 
migration studies;1,3 twin, family, and sib-pair studies; and the association 
between many attacks of MS symptoms and upper respiratory infections.1 
Another similar theory is that MS is caused by an infectious agent 
resulting in an allergic response.6 Studies have suggested that MS may be an 
autoimmune disease, whereby the body's immune system (white blood cells) 
fails to recognize "self' tissue and destroys it as though it were "foreign."1,3,4,7 
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Diagnosis of MS is based on the patient's clinical history, the neurological 
exam showing signs of progressive neurological dysfunction and the lack of a 
differential diagnosis.7 Multiple sclerosis is usually difficult to diagnose because 
many of the early signs and symptoms come and go or are even indicative of 
another disease. There is no single neurological or laboratory test that is 
definitive of MS.2 ,6 To make a conclusive MS diagnosis, however, two factors 
must be met: 1) evidence of several areas of plaque formation in different areas 
of the CNS and 2) at least two separate exacerbations of the disease.1,2,5 
Diagnosis of MS is made more certain with the help of neurological tests such as 
nuclear magnetic resonance imaging (MRI), computed tomography (CT) scan, 
cerebrospinal fluid (CSF) analysis, evoked potentials, and 
electroencephalography (EEG).1,4,6,7 While no definitive test for MS exists, MRI is 
the most sensitive test-ten times more sensitive than CT-for detecting MS 
plaques4 and can locate lesions as the disease progresses.4 ,6 Approximately 
95% of patients with MS demonstrate multiple sites of plaque formation in the 
CNS.5,6 Evoked potentials detect abnormalities in the conduction of nervous 
impulses.1,4 Lumbar puncture and CSF analysis, while not specific for MS, do 
show strong evidence of the disease.4,5 
There is no prevention or cure for MS at this time; 1-9 however, much can 
be done to aid people in functioning at their optimal level. Some treatment may 
even result in reducing the frequency and severity of atlacks.2,5,7,9 For instance, 
several new medications are used to decrease muscle spasms and stiffness; 
reduce fatigue; control bladder symptoms, sexual dysfunction, and pain; improve 
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coordination; and control depression and other mood changes. 1 Other 
medications, such as adrenal hormones and corticosteroids, help shorten 
relapses,3.7 while interferon beta 1 a and 1 b are used to modify disease activity by 
decreasing frequency and severity of relapses.s-7 Baclofen and dantrolene are 
used to reduce spasticity that is often found in patients with long-standing MS.6 
Supportive measures for individuals with MS may include physical and 
occupational therapy to maintain and increase strength and range of motion of 
involved musculature, in addition to help maintain mobility.3 Exercise programs, 
diet, adequate rest, and counseling to combat depression are other measures 
recommended for persons with MS.2•6 
In regard to exercise, it is most effective following an acute attack, during 
the remitting stage. Vigorous exercise is not recommended during acute 
relapses or with rapidly and progressing forms of MS.8 The effects of exercise 
are dependent on the damage done to the eNS; fatigability; and the severity of 
spasticity, uncoordinated movements, and weakness. The general goals of 
exercise include increasing strength, range of motion, endurance, and 
coordination. When balance deficits are observed, specific balance exercises 
should be chosen according to the specific needs of the patient. 8 For instance, a 
patient who is having difficulties with sit to stand transfers should practice 
specifically on that task. Other persons whose balance is less affected may 
benefit more from challenged balance activities, such as tandem walking, step 
up and over, side stepping, braiding, or controlling movements on a tilt board. 
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Collectively, there are approximately 40 treatments for MS available. 
Unfortunately, most have little or no effect on the disease, undoubtedly because 
the cause of MS is still unknown.1 Other less popular treatments include 
immunosuppression, transfer factor, antiviral treatment, gluten-free diet, 
unsaturated fatty acid diet, rest/exercise, and dorsal column stimulation.3 
Balance 
Balance, or postural control, is defined as "the ability to maintain or move 
within a weight bearing posture without falling."10 There are three components of 
balance: static steadiness, symmetry, and dynamic stability. Static stability is 
defined as the ability to sustain an upright posture with minimal sway. Symmetry 
is defined as having equal weight distributed between the weight bearing 
components. 11.12 Dynamic stability describes the ability to move within a given 
posture without a loss of balance (LOB).10 It is important to understand that 
static and dynamic balance are greatly affected by vestibular, visual, and 
somatosensory feedback.11-15 These postural components provide the CNS with 
afferent (sensory) input, which can then be followed by the appropriate and 
effective efferent (motor) response from the CNS. 16 When these systems are 
functioning adequately, an individual is able to maintain the center of gravity 
within the base of support with minimal extraneous movement, or sway. 
However, if one or more of these systems is compromised, which is often the 
case in persons with MS, the CNS adjusts by utilizing inputs from the remaining 
systems to maintain postural control. 13 In other words, the CNS relies more 
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heavily on the feedback from the remaining systems in order to reduce sway, a 
measure of postural control, to avoid a LOB. 
Visual Input 
The optic nerves comprise part of the CNS and are, therefore, susceptible 
to demyelination and subsequent plaque formation. In approximately 15% of 
persons with MS, optic neuritis was reported as the initial symptom.3 
Fortunately, vision usually improves within one week. It is also common for 
people with MS to experience diplopia, blurring of vision, and loss of vision. 1-9 
Persons with MS reported experiencing visual loss or diplopia as an initial 
symptom 30% of the time. Throughout the course of the disease, however, 
individuals reported experiencing some type of visual loss or diplopia 98% of the 
time. 8 Therefore, one can conclude that visual abnormalities, at least sometime 
throughout the disease process, are a problem for persons with MS. Since 
visual input is an important component in postural stability, one can then assume 
that balance may be significantly compromised unless the CNS can rely more 
heavily on the feedback from the other two components. 
Vestibular Input 
The vestibular system is responsible for detecting changes in the linear 
acceleration and deceleration forces acting on the head, as well as angular 
velocity effects on the head.11 •17 This system also provides feedback necessary 
to reference the position of the head in response to gravity. Moreover, the 
vestibular system provides the output necessary for two important reflexes, the 
vestibulospinal reflex (VSR) and the vestibulo-ocular reflex (VOR). The VSR 
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allows for head and postural control in order to prevent falls. The VOR controls 
the eye movements and allows for clear vision during head movements. 17 
Vestibular input is also responsible for the righting reflexes which, in turn, are 
responsible for allowing the body to maintain balance when confronted by 
sudden movements. The vestibular system is commonly affected by MS, with 
most persons experiencing episodes of vertigo and dizziness. Vestibular input 
becomes increasingly important in providing feedback to the eNS when the 
visual or somatosensory systems are compromised. 
Somatosensory Input 
The third component important for postural stability is the somatosensory 
system or proprioceptive component. This input is preferred by most healthy 
adults for maintaining an upright position. 13 Proprioceptive input from the 
mechanoreceptors of the foot and ankle provide input to the eNS to promote 
postural stability and reduce sway.11,18 Patients with MS reported experiencing 
sensory abnormalities of the extremities as an initial symptom of the disease 
approximately 35% of the time, compared to approximately 70% of the time 
during the course of the disease.8 It appears that impaired sensation is quite 
frequently reported as an early and late symptom of MS.1 This being the case, 
one can conclude that the somatosensory or proprioceptive input to the eNS is 
diminished in persons with MS. Unless the eNS succeeds in integrating input 
from the other two systems, balance will likely be greatly affected. 
It has been reported that balance disturbances are noted 20% of the time 
as initial symptoms of MS. Abnormalities in balance are reported to occur 80% 
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of the time throughout the course of the MS disease.8 Studies have found that 
instability and increased body sway are associated with vestibular abnormalities, 
visual problems, loss of vibration sense and lower limb tendon reflexes, and 
multi-sensory deficiencies in healthy adults.18-21 
Recent studies of patients having suffered a cerebrovascular accident 
(CVA) with resulting hemiplegia utilized force platform systems for assessing and 
retraining postural controI. 10,14,22-24 These systems provide visual and/or aud itory 
feedback to the patients regarding the position of the center of gravity (COG). 
The NeuroCom Balance Master® (NBM®) is one such piece of equipment that 
provides the patient with visual feedback of the location of the COG in relation to 
the limits of stability (LOS).14,25 The NBM® consists of a dual-force platform 
connected to a microprocessor and uses an estimate of the person's COG 
projected as a reference point on a computer screen. 25 In addition, numerous 
training protocols on the NBM® may be utilized to optimize three components of 
postural stability. These measures of postural control- static steadiness, 
symmetry, and dynamic stability-are used most often during the balance 
assessment using the force platform system. 10,26 Lee et al23 state that 
biofeedback, such as that provided by the NBM®, is a most effective method in 
improving postural instability immediately in hemiplegic subjects as well as for 
those individuals who can use the visual or auditory feedback. Other studies 
found that improvements were noticed very quickly and with very little 
treatment. 27 
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Force platform measures of postural sway have been reported to be valid 
and reliable when using the center of force versus the center of pressure 
measures. 10,26 Liston et al24 suggested that for CVA patients, complex tests of 
balance proved to be more reliable than static steadiness or symmetry tests. 
Dynamic stability measures proved to be more valid measures of functional 
balance performance than static steadiness measures. 10,24 However, Liston and 
colleagues24 found that only the LOS test among the dynamic stability measures 
was highly reliable. Liston and colleagues24 recognize that other studies have 
argued that the majority of the variables tested with the NBM® were found to be 
valid measures of balance. 24 
Force platform studies with hemiparetics have shown varied results; 
however, for the most part, some improvements in postural stability have been 
observed. 1o,11,22 Studies have suggested that symmetry and dynamic stability 
measures may provide more accurate information of patient progress. 10,27 These 
two measures show consistent improvement with use of visual biofeedback 
using force plate systems. 10,27 A study by Shumway-Cook and associates 12 
indicated that hemiplegic subjects improved in measures of static stability when 
trained with a force platform balance system. Studies showed improvements in 
stance, weight transference, and in tolerance of imposed forces. 11 ,27 While 
Liston and colleagues24 found that standing balance training in hemiparetics 
improved postural control, that improvement did not carry over to improve 
locomotor function. These studies suggest that performance is task specific. A 
study by Panzer et al29 concluded that balance retraining of hemiplegics using 
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the NBM® improved midline positioning, standing mobility, and transfers. Again, 
these improvements did not translate to improvements in functional mobility, 
such as gait. In contrast, a case study of two patients with hemiplegia, 
conducted by Sackley et al,27 suggested that training effects from visual 
biofeedback did translate to improved functional skills, thereby increasing 
activities of daily living (ADL) scores. 
When designing a treatment program utilizing the NBM® to optimize 
effectiveness, one should identify and focus on the particular needs of the 
patient. 13 It is also important to design a balance program that readily translates 
to a new learning situation. 13 A study by Maurer and colleagues 13 concluded that 
a training schedule of 20 minutes three times per week over a period of three 
weeks was just as effective as a more concentrated schedule. Further, Nichols 10 
found that programs which incorporated various training activities have provided 
consistent changes in patients' level of function, including transfers, gait, home 
mobility, endurance, functions of daily life, and gross motor function. 
Purpose of Study 
Recently, there has been a growing acceptance for the utilization of a 
force platform biofeedback system for evaluation and treatment of various 
neurological and orthopedic diagnoses.23,26,28 At this time, there is no research 
available concerning balance assessments of and retraining for patients with MS 
using a platform biofeedback system. Therefore, the purpose of this study is to 
determine if significant changes occur in static steadiness, symmetry, and 
dynamic stability following a balance retraining program on the NBM®. 
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Research Questions 
Thisresearch project will answer the following questions: 1) Is there a 
significant difference in measures of static steadiness between the control and 
treatment groups utilizing the NBM® for balance retraining? 2) Is there a 
significant difference in measures of symmetry between the control and 
treatment groups? 3) Is there a significant difference in measures of dynamic 
stability between groups with utilization of the NBM® for balance retraining? 
It is hypothesized that there will be a significant difference between the 
control and treatment groups based on a comparison of the initial to the final 
balance assessment. The alternate hypothesis states that the treatment group 
will demonstrate improvements in static steadiness, symmetry, and dynamic 
stability as compared to the control group who should demonstrate either no 
change in balance or perform slightly worse secondary to the general 
progressive course of the disease. 
Because balance is an integral part of a physical evaluation for a 
multitude of patient diagnoses, including MS, the significance of conducting this 
study involved the utilization of the NBM® to assess and retrain patients with MS 
in an objective and systematic manner. Upon completion of this study, the 
results can be useful to a clinician eager to use a force platform system with 
biofeedback to improve balance. As a physical therapist, it is important to 
examine possible therapeutic treatment modalities that may prove successful in 
treating various symptoms of MS and be able to apply the tool to other patients 
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as well. Finally, this study can be used as a basis for future research involving a 
larger sample size and/or a longer period of time for balance retraining . 
CHAPTER II 
METHODOLOGY 
An Institutional Review Board form describing the purpose and format for 
this study was completed by the researchers and approved by Altru Health 
Systems and the University of North Dakota (see Appendix A). A meeting 
between the researchers and the neurologist involved in this study was held to 
discuss selection of subjects and inclusion criteria for participation. 
Subjects 
A sample of convenience was used from a population pool of MS patients 
under the care and supervision of a neurologist. Subjects were contacted by 
telephone and scheduled for an initial assessment. Inclusion criteria for 
participation in this study consisted of: 1) a diagnosis of MS, 2) a score in the 
3.0 to 6.0 range on the Neurological Assessment Kurtzke Functional Systems-
EDSS (see Appendix B), 3) an absence of secondary diagnoses that may 
interfere with this study, 4) no prior experience using the NBM®, and 5) 
permission from the neurologist associated with this study. Subjects were 
excluded if: 1) one or more of the above criteria were not met or 2) unable to 
understand and follow instructions. 
Two groups of five subjects (mean age = 50.9 ± 4.5 years) were selected 
based upon ability to participate in this study. Those subjects who either lived in 
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rural locations or were unable to participate in the retraining program due to work 
or other time conflicts were assigned to the control group. The treatment group 
was composed of those subjects who expressed a desire to participate and were 
able to commit their time to the four-week retraining program. The control group 
consisted of five subjects (4 females, 1 male) who performed an initial and final 
balance assessment on the NBM® only. The subjects in the control group 
received no balance retraining between testing trials. The treatment group 
consisted of five subjects (2 females, 3 males) who participated in an initial and 
final balance assessment and a balance retraining program three days per week 
for four weeks. The initial and final balance assessments for both groups and 
the retraining program for the subjects in the treatment group were performed 
using the NBM®. Refer to Table 1 for descriptive data of subjects. 
Questionnaire and Initial Evaluation 
Upon arrival at the research site, subjects were given a consent form and 
a questionnaire (see Appendices C and D, respectively). The questionnaire was 
given to all ten subjects before beginning the initial assessment on the NBM®. 
Questions were related to subjective ratings of balance difficulties, number of 
falls in the last month and year, previous hospitalizations, health problems, 
medications, sensation, vision, exercise, work schedule, and use of an assistive 
device. A general screening was performed on each subject prior to beginning 
the assessment on the NBM® and consisted of manual muscle, range of motion, 
reflex, and sensation testing (see Appendix E). 
Subject Age Sex Group 
1 49 F C 
2 53 F C 
3 52 F Rx 
4 58 F C 
5 53 F Rx 
6 52 M Rx 
7 48 M Rx 
8 42 M Rx 
9 47 M C 
10 55 F C 
control mean age = 52.4 years 
treatment mean age = 49.4 years 
Table 1.-Descriptives of Subjects 
Side Assistive Balance 
Years Involved Devices Used Difficulties 
11 L cane mild 
7 L no mild 
13 R cane moderate 
6 R cane mild 
6 L cane severe 
5 L no moderate 
5 R no moderate 
14 L cane moderate 
9 R cane mild 
28 Equal cane moderate 



























The NBM® (NeuroCom® International, Inc, 9570 SE Lawnfield Road, 
Clackamas, OR 97015-9611, Telephone (800) 767-6744) used in this study is 
composed of two adjacent force platforms (each approximately 155 cm long) 
resting on four load cells which transfer information from the platform system to a 
connecting computer. 14,30 The computer monitor is located at the superior end of 
the platform and is positioned at eye level to the subject with a cursor 
representing the center of gravity (COG) as a reference point in relation to the 
theoretical limits of stability (LOS). The balance master system offers an 
objective measure of balance and balance-related activities for the patient and 
clinician by giving continuous visual feedback and statistical information 
regarding performance on each test and retraining measure. 14 The machine is 
sensitive to all types of individuals and accommodates ambulatory and non-
ambulatory populations. Objective and quantitative data are available on 
computerized printouts depicted as graphs, numerical charts, and actual picture 
representations of the assessment with tracing of the COG movement. 
Immediate results can be obtained to monitor static steadiness, symmetry, and 
dynamic stability. Visual feedback is given during retraining with the COG 
represented as a cursor and movements of the COG depicted as yellow lines 
indicating linear displacement. 
Although there has been a wide acceptance in using the NBM® in the last 
several years, only recently have reliability and validity issues been addressed. 
Liston and colleagues24 concluded that measurements of dynamic stability in 
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subjects with hemiplegia were more reliable and valid than those for static 
steadiness and symmetry. Speculation must be used when interpreting data 
from this study, in particular, because a generalization cannot be made from one 
medical diagnosis to another. Therefore, further research is needed to produce 
normative data to establish reliability and validity values for different populations 
using the NBM®. 
Hamman et al14 concluded that a high "learning curve" exists when using 
the NBM® because significant changes were seen in normal, healthy subjects 
over repeated retraining sessions. This learning effect was found to increase 
during the first few training session before gradually reaching a plateau. This 
indicates that a "learning curve" developed within a specific time period. This 
means that once a threshold has been reached, the body must use higher 
cortical processing to achieve greater levels of learning. Due to the small 
sample size in the study by Hamman et al,14 further research is needed to 
establish normative data for "learning curves" in neurological populations. 
Because MS is a complex disease with a multitude of secondary complications 
associated with the degree of eNS involvement, difficulty arises in comparing 
MS subjects to norms of different populations. 
Procedure 
An introduction to the force platform system for each subject included a 
general description of the apparatus, how performance is measured, balance 
strategies utilized to maintain balance, subject expectations, and a warm-up 
session. Subject data consisting of an identification number, date of birth, and 
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height were entered into each subject file. Before the initial balance assessment 
began, each subject was instructed in proper foot placement on the forceplates. 
Proper foot placement on the force platform system consisted of aligning 
the lateral border of each foot parallel to a transverse line and alignment of the 
medial malleolus perpendicular to this. The feet were symmetrical on the force 
platform with the exception of allowing the subject to splay the forefoot to a 
comfortable position. This same foot placement was utilized during the testing 
procedures and retraining exercises which required subjects to be in an erect, 
standing position. Subjects were instructed to wear the same shoes worn during 
the initial and final balance assessments and during balance retraining . 
Prior to testing, each subject performed a warm-up on the NBM® which 
consisted of weight shifting to 25%, 50%, 75%, and 100% LOS. The subject's 
COG was represented as a cursor located in the center of the screen. Each 
subject was instructed to lean forward, backward, and side to side; to keep the 
knees straight; and to pivot around the ankle joints to maximize the ankle 
strategy. Subjects were placed in level one, two, or three depending on the LOS 
excursion achieved. The warm-up was also used to orient the subject to the 
apparatus and to assist the subject in gaining cursor control. Once subjects 
became comfortable with the force platform system, the balance assessment 
began. 
Assessment 
An initial balance assessment was performed three days prior to week 
one of the study, and a final assessment was performed one day after week four. 
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Due to the high learning curve associated with the NB~, a warm-up and two 
initial and final assessments were completed; however, only the data from the 
second assessment were used for data analysis. 
Adequate rest periods were given between assessments as well as during 
testing or retraining when needed. Specific instructions describing each test 
were given, per NBM® manual, to all subjects prior to each assessment test. In 
this manner, the following balance tests were performed by each group during 
the initial and final balance assessments: bilateral stance, rhythmic weight 
shifting, limits of stability, walk, sit to stand, weight bearing symmetry, and step 
up/over. 
After completion of the initial assessments, the control group (n = 5) was 
scheduled for a final assessment to be performed four weeks from that date. 
After data from the initial assessment were analyzed, subjects from the control 
group received a written explanation via mail, while the subjects from the 
treatment group received a verbal explanation at their next scheduled retraining 
session regarding their balance performance on the NBM®. 
Definitions of the parameters for each assessment test are provided in the 
glossary. Refer to the glossary in Appendix F. Please refer to the NBM® 
Operator's Manual for more detailed information.3D 
Static Steadiness Test #1 
The bilateral stance test involved static standing in a predetermined area 
on the force plates for measurement of mean COG sway velocity with eyes 
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open or eyes closed. A firm surface was utilized for subjects whose LOS was 
less than 50%, while a foam surface was used for subjects exceeding 50% of 
their LOS. Standing body sway was recorded for 10 seconds, times three trials. 
The measured parameter for this test was mean COG sway velocity. 
Symmetry Test #1 
The weight bearing/squat test measured weight distribution between the 
right and left lower extremities at 0 0 and 30 0 of knee flexion. Subjects were 
required to assume a static position on the specified platform area and the force 
was recorded. A goniometer was used to accurately measure knee flexion 
during the squat. The recorded data consisted of percentages that represented 
the weight borne on each leg to show symmetry of the lower extremities for two 
trials, one at 0 0 and one at 30 0 • 
Dynamic Stability Test #1 
The LOS test involved eight targets arranged in a circular fashion around 
a central starting box. Depending on the subjects' LOS in the warm-up, the 
circular arrangement was adjusted to 50% or 75% of the measured limits. Each 
subject's COG was represented as a cursor positioned in the middle of the 
computer screen. Subjects were instructed to lean into the direction of the 
highlighted target as quickly as possible and briefly maintain a static cursor 
position on the target before returning to midline. Each subsequent target was 
highlighted in a circular fashion until all eight targets were reached. Parameters 
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measured for this test were: reaction time, sway velocity, directional control, 
endpoint excursion, and maximum excursion. 
Dynamic Test #2 
The rhythmic weight shifting test consisted of two tests: weight shift 
forward/backward and left/right. Two end-lines represented the distance each 
subject had to move during the weight shifting test. The subject was required to 
follow a small moving box which automatically moved between the two end-lines. 
Auditory and visual feedback was provided by the NBM® to assist the subject in 
moving the cursor between the points at a three-second transition rate for six 
excursions. Measured parameters included intentional or on-axis sway velocity 
and directional control. 
Dynamic Test #3 
The walk test measured several aspects of gait as the subject ambulated 
from one end of the forceplate to the other as quickly as possible. When the 
monitor displayed the word "GO," the subject walked to the end of the forceplate 
and held steady. This test is performed three times. Measured parameters were 
step width, step length, speed, and endpoint sway velocity. 
Dynamic Test #4 
The sit-to-stand test quantified several components of movement as the 
subject transferred from a seated position on a 20-inch wooden box to a 
standing position. When the word "GO" appeared on the computer screen, the 
subject rose as quickly as possible from a seated position without use of the 
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upper extremities and held steady for 20 seconds. This test was performed 
three times. Measured parameters were weight transfer time, rising index, 
COG sway velocity, and right/left weight symmetry. 
Dynamic Test #5 
The step up/over test required the subject to step up onto a four- or eight-
inch high curb (depending on each subject's performance during prior tests) with 
one leg, to swing the other foot over the curb and onto the floor, and step down 
with the curb foot. When the word "GO" appeared on the screen, the subject 
stepped up and over the box as quickly as possible and held steady for five 
seconds. The measured parameters were lift-up index, movement time, and 
impact index. The test consisted of six trials, three leading with the left foot and 
three leading with the right foot. 
Training 
The treatment group (n = 5) was seen three times per week for four weeks 
for balance retraining exercises. Subjects in both groups were instructed to 
maintain their daily activities and to avoid participating in any new extracurricular 
activities (in addition to this study), as this could skew research findings. All 
subjects were instructed to report any exacerbation of symptoms during this four-
week period. 
The balance retraining program for each subject in the treatment group 
was individualized according to performance and subject progression. Balance 
retraining exercises included seated circles on a firm 20-inch wooden box, 
29 
progressing to a 16-inch firm wooden box with a 6-inch foam cushion, and finally 
progressing to a medium-sized therapeutic ball. The progression of closed chain 
exercises consisted of forward/backward, left/right, and figure-of-8 pattern weight 
shifting with progression from a firm to foam surface and finally a tilt board. 
Mobility training involved right step, left step, and alternate stepping which was 
progressed by increasing the step length and decreasing the amount of time 
each subject was allowed during stepping. The progression of gait was from a 
wide base of support, to a medium base, to heel-toe tandem walking, as well as 
decreasing the time available to get from one end of the platform to the other. 
Stepping activities were progressed from step up, to step up/over, as well as 
step up/over and back, and increasing the height of the box from 4 inches to 8 
inches to 16 inches. Progression to a more difficult level was guided by each 
subject's performance in the exercise retraining program. 
All subjects in the treatment group completed the retraining sessions three 
days per week. Due to scheduling conflicts, two subjects needed to reschedule 
their appointments; however, all subjects completed three sessions per week 
with no absences. 
Data Analysis 
The data from the initial and final balance assessments for both the 
treatment and control groups were entered into the SPSSTM software system. 
With this program, the mean, standard deviation, standard error of the mean, the 
minimum and maximum scores, t-statistic, degrees of freedom, significance, 
mean difference, and standard error difference were calculated. These 
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parameters were used to detect significant changes in components of static 
steadiness, symmetry, and dynamic stability between groups from the initial to 
the final balance assessments on the NBM®. 
Reporting Results 
Upon completion of this study, a summary regarding the results will be 
completed and sent to each subject and to Altru Health Care Systems. A copy 
of this independent study will be given to the neurologist involved in this research 
project, the preceptor, and the University of North Dakota. This study was 
completed to fulfill the requirements for the University of North Dakota School of 
Medicine and Health Sciences Physical Therapy Program. 
CHAPTER III 
RESULTS 
An independent measures t-test was used to determine if there were 
significant changes found between groups in measures of static steadiness, 
symmetry, and dynamic stability. Two of the 43 components of balance showed 
significant changes between groups. 
Subject Profile 
Ten subjects (6 females, 4 males) participated in this study. No subjects 
were excluded and all data were used. Five subjects (4 females, 1 male) with an 
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age range of 47 to 58 and a mean age of 52.4 years participated in the control 
group. All testing for this study involved balance assessments on the NBM®. 
Subjects in the control group were seen twice over a four-week period, once for 
an initial balance assessment at week one and once for a final balance 
assessment at week four. Five subjects (2 females, 3 males) with an age range 
of 42 to 53 and a mean age of 49.4 years participated in the treatment group. 
Subjects in the treatment group were seen by the researchers for an initial 
balance assessment at week one, balance retraining three times per week for 




The independent variables (IV) in this study consisted of the treatment 
and the control groups. The dependent variables (DV) were changes between 
the initial and final balance assessments measured as "gain/loss" scores. The 
"gain/loss" score was defined as the mean change in performance between the 
initial and final balance assessments. 
Initially, data were examined using analysis of co-variance (ANCOVA). 
Fifty of the 57 statistical tests did not meet the assumptions underlying the 
ANCOVA; therefore, all analyses utilized the independent measures t-test. This 
test was used to determine if there was a significant difference in static 
steadiness, symmetry, and dynamic stability between the treatment and control 
groups. Statistical analysis was two-tailed and the level of significance was set 
at (p < 0.05) for all tests. 
Static steadiness: Is there a significant difference in measures of static 
steadiness between the control and treatment groups? Static steadiness 
was analyzed via five measures as listed in Table 2. Assumptions of the t-test 
were met in one of the five components. No significant difference was found 
between the treatment and control groups for any measure of static steadiness. 
Symmetry: Is there a significant difference in measures of symmetry 
between the control and treatment groups? Symmetry was analyzed via 
eleven measures as listed in Table 3. Assumptions of the t-test were met in all 
Table 2.-Components of the Tests for Static Steadiness 
Significance Mean 
t df (2-tailed) Difference 
COG Sway Velocity* -.572 8 .583 -.4400 
End Sway* .144 8 .889 . . 1200 
Mean Center of Gravity Sway Velocity* .292 4.174 .784 4.000E-02 
(eyes closed) 
Mean Center of Gravity Sway Velocity* 1.723 8 .123 .1400 
(eyes open) 
Mean Center of Gravity Sway Velocity .566 8 .587 4.000E-02 
jcomposi!~ ._ . ____ ._ . __ . 
* Indicates data were not normally distributed. 










Table 3.-Components of the Tests for Symmetry 
Significance Mean 
t df (2-tailed) Difference 
Impact Body Weight (left) -.201 8 .845 -1.2000 
Impact Body Weight (right) 2.088 8 .070 9.0000 
Impact Index Difference 1.091 8 .307 18.8000 
Lift-up Index Difference* 2.069 8 .072 16.4000 
Left/Right Weight Symmetry -.924 8 .382 -7.0000 
Lift-up Index Body Weight (left) -.936 8 .377 -1.8000 
Lift-up Index Body Weight (right) 1.976 8 .084 4.4000 
Rising Index .209 8 .840 .2000 
Weight Bearing (left) (0°) 1.373 8 .207 7.2000 
Weight Bearing (left) (30°) .593 8 .570 4.6000 
Weight Bearing (left) (60°) -1.189 6 .279 -9.2500 
Weight Bearing (right) (0°) -1.373 8 .207 -7.2000 
Weight Bearing (right) (30°) -.593 8 .570 -4.6000 
Weight Bearing (right) (60°) 1.189 6 .279 9.2500 
* Indicates data were not normally distributed. 




























cases. No significant difference was found between the treatment and control 
groups for any measure of symmetry. 
Dynamic stability: Is there a significant difference in measures of dynamic 
stability between the control and treatment groups? Dynamic stability was 
analyzed via 37 measures as listed in Table 4. The assumption for normal 
distribution of the independent variable was not met for 6 of the 37 components, 
and the results were analyzed only with descriptive measures. Thirty-one 
components met the assumptions of the independent measures t-test. A 
significant difference, t(8) = .042, P < .05, two-tailed was found between groups 
for the component of endpoint excursion forward. A significant difference, t(8) 
= .029, P < .05, two-tailed was also noted for the component of maximum 
excursion endpoint forward . Endpoint excursion forward was greatest for 
the treatment group, with a mean of 11.4% LOS. The mean for the control group 
was -5.6% LOS which resulted in a mean difference of 5.8% LOS between the 
groups. Maximum excursion endpoint forward was also greatest for the 
treatment group with a mean of 4% LOS. The mean for the control group mean 
was -9.4% LOS which resulted in a mean difference of -5.4% LOS between 
groups. 
Table 4.-Components of the Tests for Dynamic Stability 
Significance Mean 
t df (2-tailed) Difference 
Directional Control (composite)* 1.100 8 .303 6.6000 
Directional Control (forward/backward) .294 8 .777 4.0000 
Directional Control (left/right) 1.979 8 .083 9.4000 
Directional Control (back)* .696 8 .506 9.2000 
Directional Control (composite) .323 8 .755 1.6000 
Directional Control (forward) -1.485 8 .176 -11.2000 
Directional Control (Ieft)* -.686 8 .512 -5.8000 
Directional Control (right) 2.666 4.285 .052 14.8000 
Endpoint Excursion (back) -.513 8 .622 -6.4000 
Endoint Excursion (composite) -.921 8 .384 -5.0000 
Endpoint Excursion (forwardt -2.423 8 .042 -17.0000 
Endpoint Excursion (Ieft)* .369 8 .722 5.0000 
Endpoint Excursion (right) -.072 8 .945 -.8000 
Movement Velocity (forward) -1.286 8 .234 -.8800 
Movement Velocity (back) -2.068 8 .072 -1.0000 





















Table 4.--Components of the Tests for Dynamic Stability (Cant.) 
Significance Mean 
t df (2-tailed) Difference 
Movement Velocity (left) -1.557 8 .158 -.8000 
Movement Velocity (difference) .427 8 .680 .3400 
Movement Time (difference) .525 8 .614 2.6000 
Movement Time (left leg) 1.062 8 .319 .1240 
Movement Time (right leg) -.151 8 .884 -3.80E-02 
Maximum Excursion (back) .044 8 .966 .6000 
Maximum Excursion (composite) -.744 5.644 .487 -2.4000 
Maximum Excursion (forwardt -2.645 8 .029 -13.4000 
Maximum Excursion (Ieft)* .028 8 .978 .2000 
Maximum Excursion (right) .346 8 .738 2.4000 
On-axis Velocity (composite) -.266 8 .797 -.1200 
On-axis Velocity (forward/backward) -.727 8 .488 -.3400 
On-axis Velocity (Ieftlright)* .303 8 .770 .1600 
Reaction Time (backward) -.191 8 .853 -5.00e-02 
Reaction Time (composite) 1.284 8 .235 .1120 





















Table 4.--Components of the Tests for Dynamic Stability (Cant.) 
Reaction Time (left) 1.339 
t 
Reaction Time (right) .840 
Speed -.304 
Step Width .356 
Step Length -.305 
~ght Transfer _ .129 
_ .. -
* Indicates data were not normally distributed. 



























This chapter will discuss the findings of this research study in relation to 
previous research of balance retraining of CVA patients with hemiplegia. 
Limitations and clinical implications of this study will be addressed with 
suggestions for future research being made. 
Results 
Independent samples t-statistic values indicated that there was no 
significant difference between the control and the treatment groups on measures 
of static steadiness or symmetry. Significant differences were found between 
groups on 2 of the 31 components of dynamic stability tests. These two 
components-end-point excursion forward and maximum excursion end-
point forward-were measures of the limits of stability test. Since only 2 of the 
total 49 components of balance tests were significant, it was concluded that the 
results failed to support the alternate hypothesis which stated that there was a 
significant difference between the control and treatment groups on measures of 
static steadiness, symmetry, and dynamic stability. Even so, it is difficult to make 
conclusions regarding the results of the static steadiness tests, as only one 




One possible explanation for these findings involves the chronic, 
progressive course of MS. For example, subjective improvements in balance 
noted throughout the course of training may not have been demonstrated 
objectively during the final assessment secondary to a general decline in 
functional mobility. A second explanation is that balance retraining three times 
per week for four weeks in addition to regular functions of daily life was simply 
over-fatiguing the subjects. Several subjects throughout the course of balance 
retraining did indicate that fatigue was making it necessary for them to take more 
frequent rest periods during the day. This reported fatigue could negatively 
affect the subjects' performance during retraining as well as on the final balance 
assessment. 
Another factor that could have skewed the balance performance results is 
the possibility of non-compliant behavior on the part of the control subjects. It is 
probable that one or more subjects in the control group did not follow instructions 
to maintain their present lifestyle. In fact, one subject, upon performance of the 
final balance assessment, admitted that she had been frequently "practicing" the 
balance activities performed in the initial assessment to see if she could 
"improve" on the final assessment. The next issue addresses the probability that 
the treatment subjects were those who had more severe balance impairments 
(either subjectively or objectively) and who chose to be in the treatment group 
because of these deficits. The control subjects may have viewed their balance 
difficulties as less severe and, therefore, chose to not participate in balance 
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retraining. This issue is supported by the fewer numb.er of falls reported by the 
control subjects versus those reported by the treatment subjects. Subjects in the 
control group reported a mean of 16 falls per year; this compared to a mean of 
25 falls per year reported by the treatment subjects. In this scenario, it is 
possible that, because of the differences in initial balance performance between 
groups, the treatment subjects did improve from initial to final balance 
assessments even if these improvements were not observed between groups. 
The variable signs, symptoms, and severity of the MS disease among 
subjects could have influenced the results of this study. It was difficult, at best, 
to make judgments regarding balance performance as a group, when each 
subject varies significantly in many areas: strength, range of motion, flexibility, 
sensation, tone, endurance, balance strategies, overall functional mobility, visual 
deficits, reaction time, and use of assistive devices. The fact that there was no 
standard protocol used consistently throughout balance retraining was another 
factor that could have affected the results. In addition, the training subjects not 
only were trained at different levels according to the limits of stability (LOS) 
determined in the warm-up, but also performed various balance retraining 
exercises depending on the severity of their balance impairments. 
Random selection of subjects and subsequent random placement of each 
subject into either the control or treatment group may have resulted in more 
statistically significant findings. The researchers' relative lack of experience 
using the NBM® as well as in evaluating and treating persons with MS could have 
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further skewed performance measures. Finally, using such a small sample size 
(five subjects in each group) could have affected results. 
Previous Research 
Currently, there is no research available regarding balance assessments 
and retraining for persons with MS utilizing a biofeedback force platform system, 
such as the NBM®. Therefore, the results of this study will be compared and 
contrasted with those from previous studies on balance retraining with 
hemiplegics using a biofeedback system. Previous studies have reported that 
hemiplegic subjects show more consistent improvement on measures of 
dynamic stability than other measures of balance when incorporating feedback 
from a platform system. 10 A study by Nichols 10 reported that dynamic stability 
and symmetry measures showed consistent improvement in the retraining of 
hemiplegic patients using biofeedback. A study by Sackley27 also reported 
improvements in symmetry among hemiplegic patients. 
The results of this study with MS subjects showed that no significant 
differences were found between the control and treatment groups in measures of 
symmetry. In regard to dynamic stability, this study showed that significant 
differences between groups were found for only 2 of the 31 components of 
dynamic stability tests. A study by Shumway-Cook and associates 12 indicated 
that hemiplegic subjects improved in measures of static stability when trained 
with a force platform balance system. Such improvements or differences 
between groups were not observed among the MS subjects of this study. 
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The results cited in this discussion were based on studies of the effects of 
balance retraining on cerebrovascular accident (eVA) patients with resulting 
hemiplegia. A eVA is not a progressive disease; rather, persons having suffered 
a eVA have the potential to regain some motor and sensory function as well as 
functional mobility. Individuals with MS typically experience a progressive course 
and may not regain functional losses. Therefore, any comparisons between the 
studies with hemiplegics and this study with MS subjects must be made with 
caution. 
Limitations of Study 
A major limitation of this study is the small sample size utilized for both the 
treatment and control groups. For the results of this study to be statistically 
significant, a larger group of subjects would need to be utilized. A second 
limitation is the diversity of subjects in regard to their MS diagnoses-type, signs 
and symptoms, severity, exacerbations/remissions, level of function, and balance 
deficits. It is difficult to establish a normative sample when the subjects differ so 
greatly. 
The researchers should be proficient and well-practiced in the use of this 
biofeedback force platform system. Prior to administering the initial balance 
assessments and retraining on the NBM®, the researchers involved in this study 
each conducted balance assessments on the same three subjects. The results 
of these assessments were compared to those of the other two researchers. It 
was also required that the researchers perform a variety of the balance retraining 
protocols to gain experience as well as to establish a general protocol for the MS 
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subjects to follow. This brief training period did allow the researchers to become 
more comfortable with the NBM®; however, the researchers were completely 
inexperienced in the assessment and retraining of balance in the MS population. 
The fact that the subjects were not selected in a random fashion and were 
not assigned to groups randomly is yet another shortcoming of this study. For 
the results to be truly significant, selection would have been performed in a 
random fashion with subsequent random assignment to the treatment or control 
group. Another limitation was the limited time frame (four weeks) in which to 
carry out retraining sessions and final assessments. Perhaps with a lengthened 
training period (six to eight weeks), statistically significant findings would have 
been observed with this study. A final limitation was inadequate monitoring of 
the control subjects' compliance to maintain their present lifestyle and avoid any 
changes in physical activity. It is possible that the researchers were not clear in 
regard to these instructions provided during the initial assessment. Regardless, 
strict monitoring of control subjects is difficult, at best, especially throughout a 
four-week time period and in an outpatient type of setting . 
Clinical Implications 
Balance is an integral part of a physical assessment for a multitude of 
patient diagnoses, including MS. Therefore, the significance of this study 
involved the utilization of a biofeedback force platform system to assess and 
retrain postural stability for persons with MS in an objective manner. When 
individuals with MS demonstrate improvements in balance, they are able to 
function more independently and, as a result, gain control over one of the most 
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debilitating effects of the MS disease process. Improvements in balance and 
functional mobility also improve the person's emotional and social well-being. 
Because of the limitations of this study, the results were not as anticipated. 
Therefore, this study may be used as a basis for future research incorporating a 
larger sample size and/or a greater period of time for balance retraining. 
Future Research 
Future research should attempt to eliminate the limitations of this study. 
Sample size should include more subjects for the data to yield truly statistically 
significant results. The subjects should be selected in a random fashion and 
assigned to groups accordingly. The researchers should be experienced in 
assessment and retraining procedures utilizing the NBM®. It may be of interest 
to utilize a longer period of balance retraining for MS subjects in the treatment 
group. Studies could be done to determine the effectiveness of balance 
retraining using the NBM® for the treatment group versus a home exercise 
program of conventional balance exercises for a second treatment group in 
comparison to the control group of MS subjects. Researchers could compare 
balance performance of persons with MS to the normative data as well as to 
establish reliability and validity issues in terms of assessing balance in MS 
patients. Studies could compare the NBM®, Tinetti Gait and Balance 
Assessment, and Berg balance tests in regard to reliability, validity, and 
efficiency of balance assessment in persons with MS. 
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Conclusion 
As physical therapists, it is important to examine possible therapeutic 
treatment modalities that may prove successful in treating various diagnoses, 
including MS. Balance impairments are common in persons with MS and are 
often treated with medications or conventional balance exercises. Recently, 
biofeedback force platform systems-like the NBM®-have been utilized for 
balance retraining in persons having suffered cerebrovascular accidents with 
resulting hemiplegia as well as for a variety of other neurological and orthopaedic 
populations. Force platform studies with hemiplegics have shown varied results; 
however, for the most part, some improvements in postural stability have been 
observed. 1o,11,22 
To date, no research has been conducted using a biofeedback force 
platform to assess or retrain balance in persons with MS. Our study investigated 
the effects of a balance retraining program with MS subjects utilizing the NBM® 
force platform system. Results showed that there were no significant differences 
between the control and treatment groups on measures of static stability and 
symmetry. Further, only 2 of the 31 components of the dynamic stability tests 
showed significant differences between groups. Both components were 
parameters of the limits of stability test and measured the distance at which the 
initial movement attempt stopped or reversed while moving and the farthest 
distance the subject reached while moving forward. This finding tends to support 
studies of hemiplegics which showed significant improvements in dynamic 
stability. However, the results of this study disagree with those of hemiplegic 
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studies that found significant improvements in symmetry and static steadiness. 
Again, one should use caution when making comparisons between studies of 
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process. According to Shephard et al, who conducted a study on balance disorders in 
MS patients, balance difficulties tend to be a common problem among MS patients. 
These difficulties in balance can have severe consequences on an individual IS physica 
and psychosocial well-being. Presently, there is no cure for MS, nor is there a 
treatment to completely eliminate balance difficulties. However, many patients with 
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device for their balance difficulties. The purpose of this study is to determine if 
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2. PROTOCOL: (Descnbe procedures to which humans will be subjected.) 
Background and Objectives 
Balance difficulties are a common manifestation of multiple sclerosis. These balance 
problems are an impairment that may result in a disability or a handicap for the 
patient. Patients with MS may receive physical therapy, may perform a home exercise 
program, or may use an assistive device for their balance difficulties. The objective 
of this study is to determine if an exercise program performed on the NeuroCom 
Balance Master can improve balance over a four-week period. 
Subjects 
Ten subjects will be used in this study. Five will be involved in the control group 
and five will comprise the treatment group. All subjects involved in this study will 
have MS and will be receiving care under Dr. Teetzen, a neurologist at the Altru 
Hospital . . Patients who are ambulatory, otherwise healthy, and have physician approval 
will beasked to participate. More specifically, only those patients who are in the 
3.0-6.0 category based on the Kurtzke Scale of Multiple Sclerosis Classification will 
be asked to participate in this study (see attachment). Each subject will be informed 
of the time-frame, procedure, benefits, and risK factors associated with this study. 
In addition, all subjects will sign a statement of informed consent. 
Instrumentation 
The NeuroCom Balance Master has been shown to be a reliable and valid tool in assessin' 
balance impairments and in balance retraining in individuals suffering from cerebro-
vascular accidents, traumatic brain injuries, orthopaedic disorders, or Parkinson's 
Disease. There is limited research which utilizes the NeuroCom Balance Master for 
balance assessment and training in individuals with MS. Therefore, this research 
project will contribute to expanding research in improving balance in the MS populatio; 
Inter-reliability and intra-reliability of the researchers was determined prior to 
starting the research project by testing three individuals with no experience using thr 
NeuroCom Balance Master. Each individual was instructed and tested in four assessment 
exercises by the three members of the research team. Due to the high learning curve 
associated with the NeuroCom Balance Master, each subject was given one practice trial 
of the assessment to become familiar with the machine, and the data associated with tha 
assessment was disregarded. Each subject was re-tested two days later to establish 
intra-reliability. GOod inter- and intra-reliability was proven by comparing results 
between each tester and comparing results from retesting. Validity of the NeuroCom 
Balance Master has been established by the ability to obtain objective, quantifiable 
measurements from a computerized printout of each assessment. Information in the prin-
out includes diagrams depicting multi-directional movements, deviations in static 
positions, and tables and bar graphs organizing the data results. 
Procedure 
This study will consist of two groups of subjects, a control group and a treatment 
group. All subjects will be given a general evaluation conducted by a member of the 
research team and will include testing of general lower limb strength, flexibility, 
sensation, and reflexes. Due to a high learning curve, all subjects will be asked to 
perform a "trial" initial assessment on the NeuroCom Balance Master. The data obtaine' 
in the "trial test" will be disregarded and will be followed by a second initial 
assessment that will be recorded. The data will be used to determine each patient's 
current balance difficulties and will be used as a comparison tool to data obtained in 
the final assessment. 
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) PROTOCOL: (Con t. ) 
Procedure (Cont.) 
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The control group will only be seen twice, initially to be given a general evaluation 
by a member of the research team and to perform a "trial" and initial assessment, and 
finally to perform the same assessment after a four-week period. The treatment group 
will also be given the same general evaluation, "trial," and initial assessment, but 
this group will be involved in an exercise protocol on the NeuroCom Balance Master 
three times per week for four weeks . The exercise protocol will be the same for each 
patient and will only differ in level of difficulty, according to the patient's curren 
level of MS. At the end of the four-week period, the treatment group will also perfor' 
a final assessment. These data will be compared to the final assessment of the contro 
group along with the initial assessment of the treatment group to determine if balance 
was improved with the exercise protocol performed on the NeuroCom Balance Master. 
Subjects will be given adequate time to complete all that is asked of them during this 
study along with appropriate rest periods as determined by the subject. Participation 
in the general evaluation conducted by the researcher, the initial and final assessmen 
along with the exercise protocol will be pain-free for the patient. 
Statistical analysis of the data will consist of descriptive and analytical statistics 
A related samples t-test or the most appropriate method of statistical analysis will 
be used. All data, questionnaires, and consent forms will be kept in a confidential 
file in Meridee Green1s office at the Department-of Physical Therapy, University of 
North Dakota and will be kept for a two-year period. 
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3. BENEFITS: (Describe the benefits to the individual or society.) 
Due to the small sample size, this study may not show statistical significance; 
however, many benefits may still be observed . Upon completion of this study, the 
NeuroCom Balance Master will be a possible tool used to assist in recording accurate 
and reliable information for assessment and treating balance dysfunction in 
individuals with MS. Improvements in balance will increase their functional level 
and may promote psychological/social well-being. Findings can be used to develop 
a balance protocol for people with MS that may be used in the clinical setting and 
can help with support in cost-effective treatment for reimbursement from third 
party payers. This study can be a foundation for future research involving more 
subjects to establish normative data of balance parameters for individuals with MS 
using the NeurCom Balance Master. It will, therefore, contribute to the future for 
physical sciences and rehabilitation research. 
4. RISKS: (Describe the risks to the subject and precautions that will be taken to minimize them. The concept of risk 
goes beyond physical risk and includes risks to the subject's dignity and self respect, as well as psychological, emo-
tional or behavioral risk. If data are collected which could prove harmful or embarrassing to the subject if associated 
with him or her, then describe the methods to be used to insure the confidentiality of data obtained, including plans 
for final disposition or destruction, debriefing procedures, etc.) 
The risks associated with this study are minimal, but those that do exist will be 
controlled. The physical risks include possible loss of balance during the assess-
ment or training on the NeuroCom Balance Master. However, this risk of falling 
will be minimized by requiring subjects to wear a gait belt and having at least 
two members of the research team spotting during all testing and training procedures. 
In addition, verbal instructions will be given to subjects prior to balance 
assessment and subsequent training. Also, subjects will be given adequate rest 
periods to minimize fatigue. 
Risks to the subjects' dignity and self-respect will be accounted for and controlled 
by the research team by 1) scheduling indivjdual testing sessions to promote privacy, 
2) giving subjects complete instructions regarding their role in the research 
project, 3) providing the subjects with a safe and controlled environment in which 
to work, 4) informing the subjects that all information pertaining to history, 
performance, and functional outcomes will be disclosed with a number and no names 
will be used. Finally, the subjects will be notified that they may withdraw from 
the study at any time should an exacerbation of symptoms or any other problems arise. 
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5. CONSENT FORM: A copy of the CONSENT FORM to be signed by the subject (if applicable) and/or any statement 
to be read to the subject should be attached to this form. If no CONSENT FORM is to be used, document the proce-
dures to be used to assure that infringement upon the subject's rights will not occur. 
Describe who will be obtaining consent, where signed consent forms will be kept, and for what period of time. 
All consent forms, questionnaires, and data reports will be kept in the Physical 
Therapy Office, Room 1518 of the UNO School of Medicine and Health Sciences. Data 
and information obtained from the study will be kept in Room 1518 for two years 
following the completion of this study. Please see attached consent form. 
6. For FULL IRB REVIEW, forward the ~ original of this completed form and, copies as outlined in the attached 
instructions to: 
For EXEMPT or EXPEDITED REVIEW forward a ~ original and a copy of the consent form, questionnaires, etc., 
and any supporting documentation to: 
Eleanor Tveit, IRB Secretary 
1000 South Columbia Road 
Grand Forks, ND 58201 
701-780-6161 
-----~------------------------------------------------
The pOlicies and procedures on Use of Human Subjects in Medical Park Institutions apply to all activities involving use of 
Human Subjects performed by personnel conducting such activities. No activities are to be initiated without prior review 
and approval of the Medical Park Institutional Review Board . 
. g~~ 
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Signatures: 
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'3 - Z&.- 1<f 
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APPENDIX B 
NOTE: EDDS steps 1.0 to 4.5 reter to patients who are fully 
3mbufatory. and the Dreclse steD number Is defined by the 
.':~"cllona' System score(s). EDSS ~teps 5.0 to 9.5 are defined 
'w ihe impaIrment at JmtJulation. and usual equivalents in 
;:unctlonal System scores are provided. 
o ,'lormal ,1eurologlcal exam (all grade 0 in FS·). 
1 'J . ,\10 disability. mrnimal signs in one FS' (i.e.; grade 1). 
~ ;5 • ~Jo .:lisaollit'l . . -:irnlmal sic;ns in more than one FS' (more 
'nan one FS grade i). 
2.':; .. vlinimal disaOilil'1 in one'=S (one FS grade 2, others!):o 1). 
, .:; . "'Iinlmal :J:sacllirj :n :':10 =3 ,.:·,vo ,=S ;Jraae 2. 'JU1ers.J or i 1. 
3.J - ,vladerate disaollit'l in one ::S (one FS grade 3. others 0 or 1) 
or .nild r:!isacliil'/n :hree ;r 'our ::S (three 'Jr· four FS grade 
2, others 0 'Jr :) :rrrougn :~ily ambulalOrj. 
4.5 -
C~lIy amoulatory jut with :noderate disaoilil'! in one FS (one 
grade 3) and one or two FS grade 2; or two FS grade 3: or 
five FS grade 2 (others 0 or 1). 
=';11'1 1~:JuIJtcrj .'Jltnou; ::ICl . se!f-sutfic:ent, :';0 Jnd about 
30..-:e • 2 ~aurs 1 ".ay desc:!e relativ~ly severe disaoility con-
sisting oi one FS grade 4 ~cthers 0 or 1), or combinations of 
'~sser ;rades :xceeding :I:-:~S :;t :Jr~'Iious Sieos: ao1e :0 
walk ',vlthout aid Jr ~ast SI: .7.e SCO :r.eters. 
Fully ambulalOrj without aid. up and about much of the day, 
3ble to 'NarK a full d:!y, :nay Jtr.er'.'Iise ~ave some ;Imitation 
if :uil aC:I'IiI'J Jr i:Gulre rr.:r:lmal JSSls:ance; C:larac:emed Jy 
relatively severe disability usually consisting of one FS grade 
.! . Jthers <] 'Jr 1 \ or :ombina:ior.s of lesser gfJdes exceeding 
dml!S :i ;Jre'/icus s:~ps: :l:::~ :0 ',valk '-"I!nOut aid or iest 
50me 300 meters. 
5 n . .\mDl;lat'J~1 ·.'Iltrou~ :lid 0r ~es~ 'G~ }bc:.;: 2~0 r71eters: disaoii-
':/ S~'1er9 ~~o:.;gh ~o :rr;:air "J;( :lally 'Ic:!'mies i'e.Q .. :0 work 
a full day without s~ecial :rJ'/isions); I.lJsual FS equivalems 
1re ane lrade 5 alene. J:!"'",~S ] or 1; or combination of less-
~r ;races '1suail'! ~xcaeci:::;; :~cse tor step 4.0). 
5.;.lmoulatar/ without 3id fJr -~st :cr about; 00 :neters: disaoll-
:lj severe :!nough :0 prec::;de full daily activities: (usual FS 
equivalents are one grade 5 ~Ione, others 0 or 1; or combi-
laten ;i 'esser 'lr;:ides !Js<.lally exceeding those for step 4.0). 
n . I .. . ;,t3r:-;:::3nt .)r "..:nllater,1 ::r.srant assistance ::cane. crutch. 
!::raca) ~2qlJir2d :0 ·.'lalk ~::elJt ~ GO :neters with our without 
~esting; ~usual FS equivaiEilTS are combinations with more 
:han :11'0 FS Jrade 3ot-j. or' .;: 
6.5 - Constant :ilateral assistance (canes, crutches, braces) required 
to walk about 20 meters 'IIimaut ~esting; (usual FS equivalents 
]:e combinations ',vun :rocr:! :i'1:ln ~NO FS grade 3+). 
-; 'J - Jrable to walk aeyona apcroximately ~i'le meters 2'1en with 
lid. ~sscn!ially '9S[ilcted :0 ',vnee!cnair: wheels self in stan-
:ard 'Nheeichalr Jnd .,anstef, ]Ione: LlC and Jcout in 'Nheel-
54 
,:hJlr 'jome !:: nours 1 jay: ,iJsual ;:5 ~quivalents Jre comOI-
natronsNith :nore 'han one FS Irade ~ ... : 'terl rarely pyrami-
'JJi l;r:JG~ 5 ..ilcre l. 
7.5 - Unaole:o 'ake :nore :han a tew steps: restncted to 'Nheel-
chair: may need Jld 10 transfer; wneelS self out ~annot carr! 
·In in 3:andard ','/neelchalr a full dav; May require :notorrzed 
wheelchair; (Usual FS ~quivalents are combinations .vUh 
more than FS grade 4+) . 
8.0 - Essentially restricted :c jed or chair or perambulated in 
wheelchair, but may be out of bed itself much of the day; 
;~!arns "r.:!ny 32If-<:are :unctrons: generall" h:Js i!Hec:jl/e :.Ise 
1f arms: Js;;al FS =quivalems are comDrnations; ';enerally 
'jrJde ~- oil 32'/eral systems). 
8.5 - :ssentlally restric:ed :0 bed :nuch of day: has some ~f'ecti'le 
:.Jse 'Ji Jr:n i, Sj; -:;tains some seif-care iunC:lons: (usual .=3 
equivalents are combinations generally 4+ in several systems). 
9,0 - Helpless :Jed patient; can communicate Jnd eat; (;JslJal FS 
equivalents are combinations, mostly grade 4+). 
9.5 - Totally helpless :Jed patient; :mab!e !O communica:e ~ifec­
:;'/ely 'Jr ~arJs'.·/ailow : (~sual ;::S =qwlJalems Jre ,:omClna-
:ions, almost ail graae 4+). 
10.0- <:eathjt;e:o I,lS 
Assessment Index 
o - Normal .;alt 
- Walks r.crmally cut reDor:s fatigue ',vnic!1 interferes '.'lith 
demanoing Jc:ivities. 
2 - Abnormal gait ·Jr aplsoaic :ro.baiar.ce; ;ait Jiscrder ;$ ::otice-
able to family; able to walk 25 feet in 10 seconas or less. 
3 Walks incecencemly: 3ble :0 walk 25 fee! ,n 21] seconds 'Cr less. 
4 - Requires ~nilatefal SUDDOn: Icane, single ·:rutch) :0 walk; 
:.Jses support more :~an 30~/O 01 :::e :i~e. Walks 25 :eet in 
20 seconds ar less. 
5 Reaulres :::ilateral support ,car.es, c~:;:ches, walker! :Ina 
walks 25 feet in 20 seconas or less; or, requires Jnrlateral 
support but ',valks 25 reet in graater man 20 seconas. 
6 - Requires bilateral support and walks 25 reet in greater than 
20 seconds. May use wheelchair on occasion .• 
7 Walking limited to several slees ','/Irh jiiateral 5UOpOr:: unable 
to walk 25 feet. \1ay ~se wheelchair ior 110St actiVities, 
8 - Restricted to wheelchair: able to :ransfer independently. 
9 - Restrrcted to wheelchair; unable to transfer independently. 
("The use of a wheelchair :nay be determined by a patient'S 
lifestyle Jnd motivation.) 
Physician Siqnature ______________ _ 
Date: ____ --------------
Neurological Assessment 







1 Abnormal signs without disability 
2 = Minimal disability 
3 = ,'.!fild :c moderate paraparesis or hemiparesis; severe 
monoparesIs 
-1 Marked paraparesis or hemiparesis. moderate quadri-
naresls: or monoplegia 
5 Paraplegia. hemiplegia or marked quadriparesis 
6 Quadriplegia 
9 = Unknown 
Cerebellar Functions 
Q = ," /ermal 
1 = Abnormal signs without disabiiity 
2 ,\-lild ~:axla 
3 = Moderate truncal or limb ataxia 
~ = Severe ::itaxla in all limos 
5 Unable !o perform coordinated movements due to ataxia 
7 = When weakness (graoe 3 or worse on pyramidal) 
interferes with testing 
9 = Unknown 
J. Brainstem Functions 
o ;',JOimal 
1 Signs or.!y 
2 :"Icderate nystagmus or other mild disability 
3 ,, 'v1oderate n'lstagmus, marked extraocuiar weakness. or 
mooerate Qlsaoility Jt cmer Cranial nerves 
4 = Marked dysarthria or other marked disability 
5 = !naoility :0 swallow or speak 
9 Unknown 
4. Sensory Functions 
o = ;',Iormal 
= Vibration or figure-writing decrease only in one or two 
iirr.:;s 
2 = ~.1ild dec~ease :n !ouch or pain or pOSition sense. and/or 
moaerate decrease in 'lIb ration in one or ,,vo limbs; or 
vibratory (cis figure writing) decrease alone in three or 
four limos 
3 Moderate decrease in touch or pain or position sense. 
and/or essentially lost vibration in one or two limbs; or 
mild decrease in :oucn or pain and/or moderate 
aecrease in JII proprioceptive tests in three or four limbs 
4 Marked decrease in touch or pain or loss of propriocep-
tion alone or combined. in one or two limbs; or moder-
ate decrease in touch or pain and/ or severe propriocep-
tive decrease in more than two limbs 
5 = Loss (essentially) of sensation in one or two limbs; or 
moderate decrease in touch or pain and/or loss of pro-
prioception for most of the body below the head. 
6 Sensation essentially lost below the head 
7 = Unknown 
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S. Bowel and Bladder Functions 
o = .'lormal 
I "Mild unnar/ nesitanc'l. urgency, 'J r retention 
2 = Moderate hesltanc'!. urgency. retention ot bowel bladder 
or rare urinarl incontinence (imermittent self-cameteri-
zallon, manual compression to emoty bladder. or finger 
evacuation of stOOl) 
3 Freauent urinar/ incontinence 
4 !n need of almost constant catheterization (and constant 
use ot measures to evacuate stOOl) 
5 " Loss ot bladder function 
6 Loss of bowel and bladder function 
9 Unknown 
6. Visual (or Optic) Functions 
o = ,'Iormal 
I = Scatoma with '/isual acuity (correct2d) better :han 20/30 
2= 'Norse eye With scotoma with maximal visual acuity 
(corrected) ot 20/30 to 20/59 
3 Worse eye with large scotoma. or moderate decrease in 
fields. but With maximal Visual acuity (corrected) of 
20/60 to 20/99 
-1 " Worse eye with marked decrease of fields and maximal 
'/lsual acuity (correcteo) or 20/1 00 to 0 20/200: grade 3 
: ius maximal acuity af better )t 2(::60 Jf less 
5 Norse eye with i7:3Xlmal '/lsual aC:Jlty (correcteo) less 
:han 20/2CO: grade 4 alus ;.'!aximal acuity better eye of 
20/60 or less 
6 Grade 5 plus maximal visual Jcuity of better of 20/60 or 
;ess 
7 = Presence of temporal pallor 
9 = Unknown 
7. Cerebral (or Mental) Functions 
a = ~Jormal 
1 Mood alteration only (does not affect ass score I 
2 Mild decrease in mentation 
3 :\loderare decrease in menta::on 
4 Ivlarked decrease in mentation (chroniC brain 
syndrome - moderate) 
5 = Dementia or cnronic brain syndrome - severely 
incompetent 
9 = Unknown 
a. Other Functions 
a. = Spasticily 
o " None 
1 Mild 
2 = Moderate - (minor interference) 
3 = Severe - (major interference) 
9 = Unknown 
b. = Others 
o = None 
I = Any other neurological findings attribute MS: Specify 
o = Ur.known 
Neurological Assessment 
Kurtzke Functional Systems - ECSS 




INFORMATION AND CONSENT FORM #1 
TITLE: The Effects of Balance Training Exercises Oil the NeuroCom Balance Master ill 
Subjects with Multiple Sclerosis. 
You are invited to participate in a study conducted by Becky Coy, Jill Steinmetz, and Biana 
Zearley, physical therapy students at the University of North Dakota. The purpose of this study is 
to determine if balance exercises performed on the NeuroCom Balance Master, a machine used to 
assess balance, are effective in improving balance for an individual with Multiple Sclerosis (MS). 
Only subjects with MS who are otherwise normal and healthy and have physician approval will be 
asked to participate. 
You will be asked to report to the Physical Therapy Department at the Altru Health Institute 
Rehabilitation Hospital where a general assessment will be conducted by a member of the research 
team. We ask that you wear loose,comfortable clothing and tennis shoes when participating in 
this study. The assessment will include: general lower limb strength, flexibility, sensation, and 
reflex testing. We will be recording your name, height, and date of birth (all will be 
confidential). You will be asked to complete a questionnaire concerning balance difficulties, 
current exercise routine, activities of daily living, and whether or not you use an assistive device 
for ambulation. You will then be asked to participate in a "practice trial" assessment on the 
NeuroCom Balance Master which will take approximately 15 minutes. Following this, you will be 
asked to perform a series of tests on the machine (the actual assessment) and this will take 
approximately 30 minutes. 
You will be asked to return to the Altru Health Institute Rehabilitation Hospital fourweeks from 
the initial evaluation, it is at this time that a fmal evaluation will be conducted involving the same 
tests as before. We ask that you continue to assume you regular levels of exercise and activities 
of daily living during the four week period. 
Dr. Teetzen will be overseeing this study and two members of the research team will be present at 
all times. Throughout the experiment, we will use the NeuroCom Balance Master as an 
assessment and training tool. This machine is commonly used in physical therapy clinics across 
the nation and is a clinically accepted measure of balance. 
The results from the study will be confidential and your data will be identified by a number known 
only by the investigators. Whether or not you decide to participate in this study will not 
jeopardize your future relationship with the Physical Therapy Department or the University of 
North Dakota. If you decide to participate, you are free to discontinue participation at any time. 
The investigators involved are available to answer any current or prospective questions you have 
concerning this study. Questions may be answered by calling Becky or Jill at (701) 746-9508 or 
Biana at (701) 775-1061. A copy of this consent form is available to all participants in the study. 
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In the event that this research activity (which will be conducted at the Altru Heath Institute 
Rehabilitation Hospital) results in a physical injury, medical treatment will be available, including 
fIrst aid, emergency treatment and follow-up care as it is to members of the general public in 
similar circumstances. Payment for any such treatment must be provided by you and your third 
party payer, if any. 
ALL OF MY QUESTIONS HAVE BEEN ANSWERED AND I AM ENCOURAGED TO 
ASK ANY QUESTIONS THAT I MAY HAVE CONCERNING TIllS STUDY IN THE 
FUTURE. MY SIGNATURE INDICATES THAT, HAVING READ THE ABOVE 
INFORMATION, I HAVE DECIDED TO PARTICIPATE IN THE RESEARCH 
PROJECT. 
I have read all of the above and willingly agree to participate in this study explained to me by 
Becky Coy, Jill Steinmetz, and Biana Zearley. 
Participant's Signature Date 
Witness (not the scientist) Date 
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INFORMA nON AND CONSENT FORM #2 
TITLE: The Effects of Balance Training Exercises on the NeuroCom Balance Master in 
SUbjects with Multiple Sclerosis. 
You are invited to participate in a study conducted by Becky Coy, Jill Steirunetz, and Biana 
Zearley, physical therapy students at the University of North Dakota. The purpose of this study is 
to detennine ifbalance exercises performed on the NeuroCom Balance Master, a machine used to 
assess balance, are effective in improving balance for an individual with Multiple Sclerosis (MS). 
Only subjects with MS who are otherwise normal and healthy and have physician approval will be 
asked to participate. 
You will be asked to report to the Physical Therapy Department at the Altru Health Institute 
Rehabilitation Hospital where a general assessment will be conducted by a member of the research 
team. We ask that you wear loose, comfortable clothing and tennis shoes when participating in 
this study. The assessment will include: general lower limb strength, flexibility, sensation, and 
reflex testing. We will be recording your name, height, and date of birth (all will be 
confidential). You will be asked to complete a questionnaire concerning balance difficulties, 
current exercise routine, activities of daily living, and whether or not you use an assistive device 
for ambulation. You will then be asked to participate in a "practice trial" assessment on the 
NeuroCom Balance Master which will take approximately 15 minutes. Following this, you will be 
asked to perform a series of tests on the machine (the actual assessment) and this will take 
approximately 30 minutes. 
Your participation in the study will involve an exercise program that will be conducted on the 
NeuroCom Balance Master three days a week for four weeks, each session lasting approximately 
30 minutes. At the end of the four weeks, an initial evaluation will be conducted to determine the 
effects of the program on balance. We (the researchers) respect your time and realize this is a big 
commitment, however, we believe there will be significant improvements in balance and well 
worth your time and ours. 
Dr. Teetzen will be overseeing this study and two members of the research team will be present at 
all times. Throughout the experiment, we will use the NeuroCom Balance Master as an 
assessment and training tool. This machine is commonly used in physical therapy clinics across 
the nation and is a clinically accepted measure of balance. 
The results from the study will be confidential and your data will be identified by a number known 
only by the investigators. Whether or not you decide to participate in this study will not 
jeopardize your future relationship with the Physical Therapy Department or the University of 
North Dakota. If you decide to participate, you are free to discontinue participation at any time. 
The investigators involved are available to answer any current or prospective questions you have 
concerning this study. Questions may be answered by calling Becky or Jill at (701) 746-9508 or 
Biana at (701) 775-1061. A copy of this consent form is available to all participants in the study. 
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In the event that this research activity (which will be conducted at the Altru Heath Institute 
Rehabilitation Hospital) results in a physical injury, medical treatment will be available, including 
first aid, emergency treatment and follow-up care as it is to members of the general public in 
similar circumstances. Payment for any such treatment must be provided by you and your third 
party payer, if any. 
ALL OF MY QUESTIONS HAVE BEEN ANSWERED AND I AM ENCOURAGED TO 
ASK ANY QUESTIONS THAT I MAY HAVE CONCERNING THIS STUDY IN THE 
FUTURE. MY SIGNATURE INDICATES THAT, HAVING READ THE ABOVE 
INFORMATION, I HAVE DECIDED TO PARTICIPATE IN THE RESEARCH 
PROJECT. 
I have read all of the above and willingly agree to participate in this study explained to me by 
Becky Coy, Jill Steinmetz, and Biana Zearley. 
Participant's Signature Date 




1. Are your balance difficulties? 




2. How many times have you fallen? Did you sustain an injury, if 
so please describe it? 
in last month? 
in last year? 
ever? 
3. Have you had any previous hospitalizations or surgeries? 
4. Do you have any health problems (beyond MS) we should be aware of? 
5. Are you taking any medications? 
6. How would you describe the sensation in your feet? 
7. Do you have any difficulties with vision? 
8. How many days/week do you exercise, what type of exercise do you perform 
(walking, riding bike, treadmill)? 
9. What do you do during the day (work, stay home, etc.)? 
10. Do you use an assistive device for ambulation, if so what? 
APPENDIX E 
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L 1 inferior to inguinal ligament 
L2 anterior thigh 
L3VMO 
L4 dorsum of 151 metatarsal/medial side of foot 
L5 dorsum of foot 





1. COG sway velocity: Ratio of the distance traveled by the COG around the 
center of foot support, expressed in degrees per second. 
2. Directional control: Comparison of the amount of movement in the 
intended direction compared to the extraneous movement, expressed as a 
percentage. 
3. Endpoint excursion: Distance traveled by the COG on the primary attempt 
to reach the target expressed in percent LOS. The endpoint is considered to 
be the point at which the initial movement ceases and corrective movement 
begins. 
4. End Sway: The amount of sway occurring after changing from a dynamic to 
a static position. 
5. Impact index: The average maximum force transmitted through the lagging 
leg as it lands on the surface, expressed a percentage of body weight. 
6. Impact index difference: A comparison of the mean amount of force 
transmitted through the left and right legs, expressed as percentage. 
7. Left/right weight symmetry: The percentage of weight borne by each leg 
during static and dynamic activities. 
8. Lift-up index: The average maximum force exerted by the step-up leg, 
expressed as a percentage of body weight. 
9. Lift-up index difference: A comparison of the mean amount of force 
exerted by the left and right legs, expressed as a percentage. 
10. Maximum excursion: Furthest distance traveled by the COG during the 
trial, expressed as a percentage. 
11. Mean rising index: The average amount of force exerted by the legs during 
the rising phase, expressed as a percentage of body weight. 
12. Mean weight transfer: The average amount of time between the onset of 
the cue to move and the arrival of the COG over the feet, expressed in 
seconds. 
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13. Movement time: The average amount of time to complete the step up/over 
task, expressed in seconds. Scoring begins with the initial COG shift with 
the non-stepping leg, and ends with the impact of that leg on the surface. 
14. Movement time difference: A comparison of the mean movement times 
over the left and right legs, expressed as a percentage. 
15. Movement velocity: Average speed of COG movement expressed in 
degrees per second. 
16. On-axis velocity: The average COG movement speed in the intended 
direction, expressed in degrees per second. 
17. Reaction time: Time in seconds between signal to move and initiation of 
movement. 
18. Speed: The rate of ambulation measured in centimeters. 
19. Step length: Distance between heel contact of one foot to the contralateral 
foot during ambulation measured in centimeters. 
20. Step width: Distance between the feet during ambulation in centimeters. 
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